Publication | Closed Access

A sensitive assay to measure biomarker glycosylation demonstrates increased fucosylation of prostate specific antigen (PSA) in patients with prostate cancer compared with benign prostatic hyperplasia

GlycoproteomicsBiomarker (Medicine)UrologyOncologyGenitourinary CancerMedicineGlycobiologyPathologyProstate Specific AntigenBenign Prostatic HyperplasiaProstatic DiseaseMolecular DiagnosticsSensitive AssayGlycosylation